Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPV4 | Q9HBA0 | 2/20 | 0.46 |
| ▸ | EPAS1 | Q99814 | 11/20 | 0.44 |
| ▸ | RAD51 | Q06609 | 1/20 | 0.40 |
| ▸ | ACLY | P53396 | 1/20 | 0.40 |
| ▸ | CCR2 | P41597 | 1/20 | 0.40 |
| ▸ | SLC6A9 | P48067 | 1/20 | 0.39 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.39 |
| ▸ | VEGFA | P15692 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30915553 | 1.00 | TRPV4 (0.46) | TRPV4EPAS1RAD51ACLYCCR2 | |
| SCHEMBL15412234 | 0.85 | ACLY (0.49) | TRPV4EPAS1RAD51ACLY | |
| SCHEMBL30033203 | 0.81 | TRPV4 (0.63) | TRPV4EPAS1RAD51ACLYHSD11B1 | |
| SCHEMBL30034664 | 0.81 | TRPV4 (0.46) | TRPV4EPAS1RAD51ACLY | |
| SCHEMBL12212859 | 0.81 | TRPV4 (0.46) | TRPV4RAD51ACLYHSD11B1 | |
| SCHEMBL2889391 | 0.81 | TRPV4 (0.63) | TRPV4EPAS1RAD51ACLYHSD11B1 | |
| SCHEMBL2775587 | 0.81 | TRPV4 (0.46) | TRPV4EPAS1RAD51ACLY | |
| SCHEMBL11945262 | 0.81 | TRPV4 (0.43) | TRPV4EPAS1RAD51ACLYCCR2 | |
| SCHEMBL12966141 | 0.79 | L3MBTL1 (0.53) | TRPV4EPAS1RAD51HSD11B1 | |
| SCHEMBL6720066 | 0.78 | PTGS2 (0.50) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118054087-A | Electrolyte, electrolyte injection method and lithium metal battery | 蜂巢能源科技股份有限公司 | 2024-05-17 | — | — | CN | claimed |
| CN-118054087-A | Electrolyte, electrolyte injection method and lithium metal battery | 蜂巢能源科技股份有限公司 | 2024-05-17 | — | — | CN | disclosed |
| US-8754112-B2 | Sulfone derivative | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2014-06-17 | — | — | US | disclosed |
| US-8754112-B2 | Sulfone derivative | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2014-06-17 | — | — | US | disclosed |
| US-8754112-B2 | Sulfone derivative | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2014-06-17 | — | — | US | disclosed |
| EP-2468737-B1 | SULFONE DERIVATIVE | DAIICHI SANKYO CO LTD (JP) | 2013-10-30 | — | — | EP | disclosed |
| EP-2468737-A1 | SULFONE DERIVATIVE | Daiichi Sankyo Company, Limited (JP) | 2012-06-27 | — | — | EP | disclosed |
| US-20120129891-A1 | SULFONE DERIVATIVE | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2012-05-24 | — | — | US | disclosed |
| US-20120129891-A1 | SULFONE DERIVATIVE | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2012-05-24 | — | — | US | disclosed |
| US-20120129891-A1 | SULFONE DERIVATIVE | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2012-05-24 | — | — | US | disclosed |
| WO-2011016470-A1 | SULFONE DERIVATIVE | 第一三共株式会社 (JP) | 2011-02-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120129891-A1 | SULFONE DERIVATIVE | SLC5A1, SLC5A2, SLC2A1 | TRPV4 2452/4885EPAS1 1318/4885RAD51 4343/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.